Evidence map›Paper›PMID 41189053›Full record

ArticleNucleic acids research2025

Proteolytic cleavage activates the mitochondrial isoform of TOP3A.

Direnis Erdinc, Christin A Albus, Alejandro Rodríguez-Luis, Katja E Menger, Annika Thorsell, Ilian Atanassov, Urška Rovšnik, Maria Falkenberg, Claes M Gustafsson, Thomas J J Nicholls

Abstract read
In one paragraph

Article in Nucleic acids research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Direnis ErdincDepartment of Medical Biochemistry and Cell Biology, University of Gothenburg, SE-405 30 Gothenburg, Sweden.ORCID 0000-0002-5830-9911
Christin A AlbusBiosciences Institute, Faculty of Medical Sciences, Newcastle University, Newcastle upon Tyne NE2 4HH, United Kingdom.ORCID 0000-0002-6259-7151
Alejandro Rodríguez-LuisBiosciences Institute, Faculty of Medical Sciences, Newcastle University, Newcastle upon Tyne NE2 4HH, United Kingdom.ORCID 0000-0003-3989-1317
Katja E MengerBiosciences Institute, Faculty of Medical Sciences, Newcastle University, Newcastle upon Tyne NE2 4HH, United Kingdom.ORCID 0000-0002-6972-7326
Annika ThorsellProteomics Core Facility at Sahlgrenska Academy, University of Gothenburg, SE-405 30 Gothenburg, Sweden.
Ilian AtanassovProteomics Core Facility, Max-Planck-Institute for Biology of Ageing, 50931 Cologne, Germany.ORCID 0000-0001-8259-2545
Urška RovšnikDepartment of Medical Biochemistry and Cell Biology, University of Gothenburg, SE-405 30 Gothenburg, Sweden.ORCID 0000-0001-5889-6899
Maria FalkenbergDepartment of Medical Biochemistry and Cell Biology, University of Gothenburg, SE-405 30 Gothenburg, Sweden.ORCID 0000-0001-8713-173X
Claes M GustafssonDepartment of Medical Biochemistry and Cell Biology, University of Gothenburg, SE-405 30 Gothenburg, Sweden.ORCID 0000-0003-3531-8468
Thomas J J NichollsBiosciences Institute, Faculty of Medical Sciences, Newcastle University, Newcastle upon Tyne NE2 4HH, United Kingdom.ORCID 0000-0002-3034-4109

Funding

European Union's Horizon 2020Knut and Alice Wallenberg FoundationMarie Sklodowska-Curie Actions 721757Rosetrees and Stoneygate Trust M811Rosetrees Trust PhD2022/100035Royal Society 213464/Z/18/ZSwedish Cancer FoundationSwedish government ALFGBG-965954Swedish government ALFGBG-966275Swedish Research Council 2021-00932Swedish Research Council 2022-00976Wellcome Trust
6 · The paper itself

Abstract

The TOP3A gene encodes two isoforms, one targeted to the nucleus and one to mitochondria. Nuclear TOP3A functions as part of the BTRR complex to resolve double Holliday junctions during homologous recombination, while the mitochondrial isoform separates hemicatenated daughter mitochondrial DNA (mtDNA) molecules following DNA replication. Here, we show that the mitochondrial isoform of TOP3A undergoes proteolytic cleavage by the mitochondrial processing peptidase, removing ~90 amino acids from the C-terminus. This cleavage enhances the enzyme's biochemical properties, increasing single-stranded DNA binding and decatenation activity. Notably, all BTRR complex subunits, except TOP3A, are absent from mitochondria, suggesting that proteolytic processing enables TOP3A to function autonomously in mtDNA maintenance. We propose that this cleavage represents a post-import maturation step that tailors TOP3A to its mitochondrial context by uncoupling it from nuclear protein interactions and enhancing its catalytic efficiency.

Indexed as

DNA Topoisomerases, Type IIMitochondriaDNA, MitochondrialHumansMitochondrial ProteinsPoly-ADP-Ribose Binding ProteinsProtein IsoformsProteolysisDNA, MitochondrialDNA Topoisomerases, Type IIMitochondrial ProteinsPoly-ADP-Ribose Binding ProteinsProtein Isoforms

Identifiers

PMID41189053
PMCPMC12585908

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.